COVID-19 and immune-mediated inflammatory diseases: effect of disease and treatment on COVID-19 outcomes and vaccine responses.


Journal

The Lancet. Rheumatology
ISSN: 2665-9913
Titre abrégé: Lancet Rheumatol
Pays: England
ID NLM: 101765308

Informations de publication

Date de publication:
Oct 2021
Historique:
pubmed: 7 9 2021
medline: 7 9 2021
entrez: 6 9 2021
Statut: ppublish

Résumé

At the beginning of the COVID-19 pandemic, patients with immune-mediated inflammatory diseases were considered to be at high risk for SARS-CoV-2 infection and the development of severe COVID-19. Data collected over the past year, however, suggest that a diagnosis of inflammatory arthritis, psoriasis, or inflammatory bowel diseases does not increase risk for SARS-CoV-2 infection or severe COVID-19 compared with people without these diseases. Furthermore, substantial data suggest that certain medications frequently used in patients with immune-mediated inflammatory diseases, in particular cytokine inhibitors, might even lower the risk for severe COVID-19. Conversely, glucocorticoids and potentially B-cell-depleting treatments seem to worsen COVID-19 outcomes. Additionally, the first data on SARS-CoV-2 vaccination in patients with these diseases suggest that tolerability of vaccination in patients with immune-mediated inflammatory diseases is good, although the immune response to vaccination can be somewhat reduced in this patient group, particularly those taking methotrexate or CD20-targeted treatment.

Identifiants

pubmed: 34485930
doi: 10.1016/S2665-9913(21)00247-2
pii: S2665-9913(21)00247-2
pmc: PMC8397302
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

e724-e736

Informations de copyright

© 2021 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

KT reports honoraria for lectures from UCB and Gilea. MS reports honoraria for lectures from Abbvie, Amgen, Celgene, Hexal, Jannsen, Leo, Lilly, Pfizer, Merck Sharpe & Dome, Mundipharma, Novartis, Sanofi, UCB; support for attending meetings from Abbvie, Celgene, Hexal, Jannsen, Leo, Lilly, Pfizer, Novartis, UCB; and participation advisory boards from Abbvie, Amgen, Celgene, Hexal, Jannsen, Leo, Lilly, Pfizer, Merck Sharpe & Dome, Mundipharma, Novartis, Sanofi, and UCB. MN reports consulting fees from Boehringer Ingelheim, IFM Therapeutics, Sterna Biologicals, Pentax; and honoraria for lectures from Abbvie, Amgen, Celgene, Falk, Janssen, Merck Sharpe & Dome, and Takeda. GS reports honoraria for lectures from Abbvie, Bristol Myers Squibb, Eli Lilly, Gilead, Janssen, Novartis, Pfizer, UCB; and consulting fees from Eli Lilly, Janssen, Novartis.

Références

Br J Dermatol. 2021 Sep;185(3):646-648
pubmed: 33982284
Lancet Gastroenterol Hepatol. 2020 May;5(5):425-427
pubmed: 32171057
Arthritis Rheumatol. 2020 Oct;72(10):1600-1606
pubmed: 32506699
Gut. 2020 Jul;69(7):1213-1217
pubmed: 32354990
Arthritis Rheumatol. 2021 Dec;73(12):2179-2188
pubmed: 33955209
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
N Engl J Med. 2021 Feb 25;384(8):693-704
pubmed: 32678530
Arthritis Res Ther. 2020 Dec 30;22(1):290
pubmed: 33380344
Ann Rheum Dis. 2021 Oct;80(10):1357-1359
pubmed: 33975857
J Crohns Colitis. 2021 May 4;15(5):864-868
pubmed: 33211810
Ann Rheum Dis. 2021 Oct;80(10):1312-1316
pubmed: 33958324
J Eur Acad Dermatol Venereol. 2020 Dec;34(12):e776-e778
pubmed: 32780905
Gut. 2021 Apr;70(4):725-732
pubmed: 33082265
ACR Open Rheumatol. 2021 May;3(5):333-340
pubmed: 33856739
Ann Rheum Dis. 2021 Sep;80(9):1137-1146
pubmed: 34049860
Nature. 2020 Oct;586(7830):594-599
pubmed: 32998157
Lancet Rheumatol. 2021 Jun;3(6):e419-e426
pubmed: 33786454
Ann Rheum Dis. 2022 Jul;81(7):e131
pubmed: 32586922
Ann Rheum Dis. 2021 Jun;80(6):e99
pubmed: 32769153
JAMA Intern Med. 2021 Jan 1;181(1):24-31
pubmed: 33080005
Arthritis Rheumatol. 2020 Dec;72(12):1981-1989
pubmed: 32725762
Br J Haematol. 2020 Jul;190(2):185-188
pubmed: 32557623
Ann Rheum Dis. 2021 May;80(5):e67
pubmed: 32591357
BMC Musculoskelet Disord. 2012 Aug 27;13:158
pubmed: 22925480
Joint Bone Spine. 2021 Jan;88(1):105095
pubmed: 33152484
Lancet Rheumatol. 2021 Jul;3(7):e481-e488
pubmed: 33942031
J Hosp Med. 2020 Aug;15(8):489-493
pubmed: 32804611
Ann Rheum Dis. 2021 Oct;80(10):1351-1352
pubmed: 34031032
Lancet Gastroenterol Hepatol. 2021 Jul;6(7):528-529
pubmed: 34048723
J Rheumatol. 2018 Jun;45(6):733-744
pubmed: 29545454
An Bras Dermatol. 2015 Jan-Feb;90(1):9-20
pubmed: 25672294
Int J Dermatol. 2020 Aug;59(8):e266-e267
pubmed: 32516447
Am J Clin Dermatol. 2020 Oct;21(5):749-751
pubmed: 32812188
RMD Open. 2019 Jun 9;5(1):e000935
pubmed: 31245055
Curr Probl Dermatol. 2018;53:15-27
pubmed: 29131034
Arthritis Rheumatol. 2020 Sep;72(9):e1-e12
pubmed: 32734689
Inflamm Bowel Dis. 2020 May 12;26(6):797-808
pubmed: 32333601
Ann Rheum Dis. 2020 Oct;79(10):1382-1383
pubmed: 32398281
Gastroenterology. 2020 Oct;159(4):1541-1544.e2
pubmed: 32479824
Rheumatology (Oxford). 2013 Jan;52(1):53-61
pubmed: 23192911
Br J Dermatol. 2020 Aug;183(2):373-374
pubmed: 32343839
Ann Rheum Dis. 2021 Mar 1;:
pubmed: 33648957
Rheumatol Int. 2020 Dec;40(12):2015-2021
pubmed: 32945944
Nat Rev Immunol. 2020 May;20(5):271-272
pubmed: 32296135
Liver Transpl. 2020 Jun;26(6):832-834
pubmed: 32196933
Ann Rheum Dis. 2021 Oct;80(10):1355-1356
pubmed: 33958323
Nat Commun. 2020 Nov 12;11(1):5749
pubmed: 33184277
Clin Rheumatol. 2020 Nov;39(11):3195-3204
pubmed: 32852623
N Engl J Med. 2021 Jul 29;385(5):406-415
pubmed: 34133856
Ther Adv Musculoskelet Dis. 2021 Feb 04;13:1759720X20962692
pubmed: 33613703
Gastroenterology. 2020 Aug;159(2):481-491.e3
pubmed: 32425234
J Am Acad Dermatol. 2011 Jun;64(6):1035-50
pubmed: 21315483
Arthritis Rheumatol. 2022 Jan;74(1):33-37
pubmed: 34196506
J Am Acad Dermatol. 2021 May;84(5):1254-1268
pubmed: 33422626
Ann Rheum Dis. 2021 Oct;80(10):1339-1344
pubmed: 34035003
Ann Rheum Dis. 2021 Mar;80(3):384-391
pubmed: 33051220
Lancet Rheumatol. 2020 May;2(5):e254-e255
pubmed: 32368736
Dermatol Ther. 2020 Sep;33(5):e13475
pubmed: 32356577
Nature. 2020 Aug;584(7821):430-436
pubmed: 32640463
Ann Rheum Dis. 2021 Jan;80(1):e10
pubmed: 32312768
N Engl J Med. 2020 Dec 10;383(24):2333-2344
pubmed: 33085857
N Engl J Med. 2020 Dec 17;383(25):2427-2438
pubmed: 32991794
Clin Exp Rheumatol. 2018 Mar-Apr;36(2):317-328
pubmed: 29303710
Ann Rheum Dis. 2020 Dec;79(12):1544-1549
pubmed: 32796045
J Invest Dermatol. 2015 Dec;135(12):2955-2963
pubmed: 26214380
Gastroenterology. 2020 Sep;159(3):1141-1144.e2
pubmed: 32387541
RMD Open. 2019 Sep 19;5(2):e001041
pubmed: 31673420
Best Pract Res Clin Rheumatol. 2021 Mar;35(1):101665
pubmed: 33648855
Ann Rheum Dis. 2015 Dec;74(12):2107-16
pubmed: 26395500
Ann Rheum Dis. 2020 Jul;79(7):859-866
pubmed: 32471903
J Intern Med. 2021 Apr;289(4):523-531
pubmed: 32976665
Nat Clin Pract Gastroenterol Hepatol. 2008 Jan;5(1):18-27
pubmed: 18174904
Rheumatology (Oxford). 2021 Jan 5;60(1):399-407
pubmed: 33020836
J Transl Med. 2014 Mar 22;12:77
pubmed: 24655394
Ann Rheum Dis. 2021 Jun;80(6):698-706
pubmed: 33547062
Nat Commun. 2020 Jul 24;11(1):3774
pubmed: 32709909
JAMA Intern Med. 2021 Jan 1;181(1):32-40
pubmed: 33080017
J Infect. 2020 Aug;81(2):318-356
pubmed: 32333918
Gastroenterology. 2020 Jul;159(1):371-372
pubmed: 32247695
Am J Epidemiol. 2013 Feb 15;177(4):292-8
pubmed: 23371353
Lancet. 2015 Jul 18;386(9990):258-65
pubmed: 25975452
RMD Open. 2021 Feb;7(1):
pubmed: 33574116
Ann Rheum Dis. 2021 Oct;80(10):e159
pubmed: 34031031
Rev Infect Dis. 1989 Nov-Dec;11(6):954-63
pubmed: 2690289
Lancet. 2020 Mar 28;395(10229):1033-1034
pubmed: 32192578
Ann Rheum Dis. 2021 Oct;80(10):1306-1311
pubmed: 33762264
Clin Exp Rheumatol. 2021 Jan-Feb;39 Suppl 128(1):13
pubmed: 33338005
J Allergy Clin Immunol. 2021 Jan;147(1):60-71
pubmed: 33075408
Lancet Gastroenterol Hepatol. 2020 Jan;5(1):17-30
pubmed: 31648971
J Rheumatol. 2020 Aug 1;47(8):1296
pubmed: 32335513
Infect Dis Clin North Am. 2001 Jun;15(2):423-32, viii
pubmed: 11447704
J Crohns Colitis. 2020 Oct 21;14(14 Suppl 3):S798-S806
pubmed: 32722754
J Autoimmun. 2021 Mar;118:102613
pubmed: 33592545
Clin Rheumatol. 2007 May;26(5):663-70
pubmed: 17186117
Gut. 2021 Oct;70(10):1884-1893
pubmed: 33903149
Ann Rheum Dis. 2021 Jul;80(7):930-942
pubmed: 33504483
J Am Acad Dermatol. 2020 Jul;83(1):285-287
pubmed: 32330632
J Adv Res. 2018 Sep 19;15:87-93
pubmed: 30581616
Semin Arthritis Rheum. 2010 Apr;39(5):327-46
pubmed: 19117595
Nature. 2020 Mar;579(7798):265-269
pubmed: 32015508

Auteurs

Filippo Fagni (F)

Department of Internal Medicine 3, Friedrich-Alexander University Erlangen-Nuermberg, Erlangen, Germany.
Deutsches Zentrum Immuntherapie, Friedrich-Alexander University Erlangen-Nuermberg, Erlangen, Germany.

David Simon (D)

Department of Internal Medicine 3, Friedrich-Alexander University Erlangen-Nuermberg, Erlangen, Germany.
Deutsches Zentrum Immuntherapie, Friedrich-Alexander University Erlangen-Nuermberg, Erlangen, Germany.

Koray Tascilar (K)

Department of Internal Medicine 3, Friedrich-Alexander University Erlangen-Nuermberg, Erlangen, Germany.
Deutsches Zentrum Immuntherapie, Friedrich-Alexander University Erlangen-Nuermberg, Erlangen, Germany.

Verena Schoenau (V)

Department of Internal Medicine 3, Friedrich-Alexander University Erlangen-Nuermberg, Erlangen, Germany.
Deutsches Zentrum Immuntherapie, Friedrich-Alexander University Erlangen-Nuermberg, Erlangen, Germany.

Michael Sticherling (M)

Deutsches Zentrum Immuntherapie, Friedrich-Alexander University Erlangen-Nuermberg, Erlangen, Germany.
Department of Dermatology, Friedrich-Alexander University Erlangen-Nuermberg, Erlangen, Germany.

Markus F Neurath (MF)

Deutsches Zentrum Immuntherapie, Friedrich-Alexander University Erlangen-Nuermberg, Erlangen, Germany.
Department of Internal Medicine 1, Friedrich-Alexander University Erlangen-Nuermberg, Erlangen, Germany.

Georg Schett (G)

Department of Internal Medicine 3, Friedrich-Alexander University Erlangen-Nuermberg, Erlangen, Germany.
Deutsches Zentrum Immuntherapie, Friedrich-Alexander University Erlangen-Nuermberg, Erlangen, Germany.

Classifications MeSH